{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:09:12Z","timestamp":1762956552951,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.rceng.2020.04.012","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T17:04:07Z","timestamp":1619370247000},"page":"331-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Statin adherence and health outcomes after st-elevation myocardial infarction: 1-year follow-up study"],"prefix":"10.1016","volume":"221","author":[{"given":"A.","family":"Padilla L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2020.04.012_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.phrs.2014.02.009","article-title":"Cardiovascular effects of statins, beyond lipid-lowering properties","volume":"88","author":"Mihos","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.rceng.2020.04.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.recesp.2017.10.048","article-title":"Gu\u00eda ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevaci\u00f3n del segmento ST","volume":"70","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Rev Esp Cardiol"},{"author":"National Institute for Health and Care Excellence","key":"10.1016\/j.rceng.2020.04.012_bib0015"},{"key":"10.1016\/j.rceng.2020.04.012_bib0020","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0025","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2011.522","article-title":"Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction","volume":"305","author":"Jernberg","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.rceng.2020.04.012_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.recesp.2014.03.010","article-title":"Pron\u00f3stico y manejo del s\u00edndrome coronario agudo en Espa\u00f1a en 2012: estudio DIOCLES","volume":"68","author":"Barrab\u00e9s","year":"2015","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0035","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","article-title":"Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014","volume":"38","author":"Szummer","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rceng.2020.04.012_bib0040","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","article-title":"Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015","volume":"136","author":"Puymirat","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.rceng.2020.04.012_bib0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.recesp.2015.08.010","article-title":"Tendencias en factores de riesgo y tratamientos en pacientes con cardiopat\u00eda isqu\u00e9mica estable atendidos en consultas de cardiolog\u00eda entre 2006 y 2014","volume":"69","author":"Cordero","year":"2016","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0050","article-title":"Risk factors and therapeutic coverage at 6 years in patients with previous myocardial infarction: the CASTUO study","volume":"2","author":"F\u00e9lix-Redondo","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.rceng.2020.04.012_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12872-017-0493-6","article-title":"Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion","volume":"17","author":"Ribas","year":"2017","journal-title":"BMC Cardiovasc Disor"},{"key":"10.1016\/j.rceng.2020.04.012_bib0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.atherosclerosis.2018.02.024","article-title":"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: insights from Italian general practice","volume":"271","author":"Arca","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rceng.2020.04.012_bib0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rceng.2020.04.012_bib0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11886-011-0221-2","article-title":"Predictors of statin adherence","volume":"13","author":"Mauskop","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.rceng.2020.04.012_bib0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bcp.12339","article-title":"Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review","volume":"78","author":"De Vera","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1592\/phco.2005.25.8.1035","article-title":"Cardiovascular morbidity associated with nonadherence to statin therapy","volume":"25","author":"Blackburn","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rceng.2020.04.012_bib0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2125.2008.03212.x","article-title":"Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome","volume":"66","author":"Wei","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0090","first-page":"689","article-title":"Statin adherence and mortality in patients enrolled in a secondary prevention program","volume":"15","author":"McGinnis","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.rceng.2020.04.012_bib0095","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"Ho","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.rceng.2020.04.012_bib0100","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/pds.3840","article-title":"Effect of adherence to evidence-based therapy after acute myocardial infarction on all-cause mortality","volume":"24","author":"Hamood","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rceng.2020.04.012_bib0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00228-014-1793-8","article-title":"Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study","volume":"71","author":"Lenzi","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0110","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2017.07.783","article-title":"Adherence trade-off to multiple preventive therapies and all-cause mortality after acute myocardial infarction","volume":"70","author":"Korhonen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.acvd.2010.05.003","article-title":"Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization","volume":"103","author":"Tuppin","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.rceng.2020.04.012_bib0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011378","article-title":"It\u2019s not too late to improve statin adherence: association between changes in statin adherence from before to after acute myocardial infarction and all-cause mortality","volume":"8","author":"Hickson","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rceng.2020.04.012_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clinthera.2018.11.012","article-title":"Post-myocardial infarction (mi) care: medication adherence for secondary prevention after MI in a large real-world population","volume":"41","author":"Huber","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.rceng.2020.04.012_bib0130","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/eurheartj\/ehz714","article-title":"Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry","volume":"41","author":"Bj\u00f6rklund","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rceng.2020.04.012_bib0135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005455","article-title":"Medical therapy utilization and long-term outcomes following percutaneous coronary intervention","volume":"12","author":"Xie","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.rceng.2020.04.012_bib0140","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.rceng.2020.04.012_bib0145","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.recesp.2011.03.017","article-title":"An\u00e1lisis de riesgos competitivos","volume":"64","author":"Pintilie","year":"2011","journal-title":"Rev Esp Cardiol"},{"author":"R Development Core Team","key":"10.1016\/j.rceng.2020.04.012_bib0150"},{"key":"10.1016\/j.rceng.2020.04.012_bib0155","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of non-adherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rceng.2020.04.012_bib0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2047487317744363","article-title":"Age and gender differences in medical adherence after myocardial infarction: women do not receive optimal treatment \u2013 The Netherlands claims database","volume":"25","author":"Eindhoven","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0165","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1177\/2047487319861219","article-title":"Age, race\/ethnicity, and comorbidities predict statin adherence after ischemic stroke or myocardial infarction","volume":"27","author":"Chan","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0170","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.amjcard.2014.02.034","article-title":"Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"113","author":"Navarese","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rceng.2020.04.012_bib0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1157\/13100222","article-title":"Efecto de una intervenci\u00f3n global sobre el control integral de m\u00faltiples factores de riesgo en pacientes con alto o muy alto riesgo cardiovascular. Estudio CIFARC 2","volume":"207","author":"De la Pe\u00f1a Fern\u00e1ndez","year":"2007","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rceng.2020.04.012_bib0180","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rce.2018.06.005","article-title":"Complejidad terap\u00e9utica: un nuevo reto","volume":"218","author":"Riera-Mestre","year":"2018","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rceng.2020.04.012_bib0185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.rce.2014.03.008","article-title":"Adherencia terap\u00e9utica en la enfermedad cr\u00f3nica: estado de la situaci\u00f3n y perspectiva de futuro","volume":"214","author":"Conthe","year":"2014","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rceng.2020.04.012_bib0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1345\/aph.1L496","article-title":"Comparison of methods to assess medication adherence and classify nonadherence","volume":"43","author":"Hansen","year":"2009","journal-title":"Ann Pharmacother"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225488742100059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S225488742100059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:48:48Z","timestamp":1762418928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S225488742100059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S225488742100059X"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2020.04.012","relation":{},"ISSN":["2254-8874"],"issn-type":[{"type":"print","value":"2254-8874"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin adherence and health outcomes after st-elevation myocardial infarction: 1-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2020.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2020.04.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights reserved.","name":"copyright","label":"Copyright"}]}}